Prostate Cancer

There is hope, innovation and support available for those with prostate cancer here at the U-M Comprehensive Cancer Center.
Contact us: 800-865-1125

Patient Care and Treatment

The Urologic Oncology Program follows a team approach to diagnosing and treating those with prostate cancer. Our patients have their situation discussed not only by our urologic oncologists and surgeons, but also by experts in radiation oncology and pathology. By having everyone involved, a personalized treatment plan is developed. All of this takes place in our Multidisciplinary Urologic Oncology Clinic.

In addition, we recognize the important needs of men diagnosed with high-risk or advanced cancer and offer advanced cancer care, individual genetic analysis and precise treatment. Learn more on our High Risk Prostate Cancer webpage.


Since our program is part of the U-M Comprehensive Cancer Center, our patients have access to Patient Support Services. To fully understand what this means, please take time to visit the Patients Support Services of this website. We outline the services available to our patients at every point in their care.

Ganesh Palapattu, M.D., discusses Prostate Cancer Treatment at the U-M Comprehensive Cancer Center

If you are having trouble viewing this video, watch it on our YouTube channel.

Clinical Trials and Research

The Urologic Oncology Program is the recipient of a $6.5 million Specialized Program of Research Excellence grant in prostate cancer, a George M. O'Brien Urology Research Center grant, a PO1 in prostate cancer metastasis to bone, and two T32 Urology Training Grants. Active laboratory programs include work in the areas of prostate cancer genetics, gene discovery, metastasis, biomarker discovery, therapeutic development, and prostate and bladder cell biology. Recently, research has expanded broadly into specific evaluation of quality-of-life outcomes analyses for localized and metastatic bladder and prostate cancers. Clinical trials involving gene therapy, chemotherapy, immunotherapy and targeted agents are available for prostate, bladder and renal-cell cancers. View prostate cancer clinical trials.

Make an appointment/referral or have your questions answered

The Cancer AnswerLine is staffed by oncology nurses and is just a phone call away to answer your questions or to assist you in making an appointment.

Please call 800-865-1125 or e-mail us to make an appointment or for the answers to the questions you may have.

If you would like to refer a patient, please contact our M-Line service: 800-962-3555.

For more information, visit our Make an Appointment web page.

back to top